Abstract: The present invention is directed toward substituted hydroxyethylene compounds of formulas (XII) (XIII), and (XIV) useful in treating Alzheimer's disease and other similar diseases.
Type:
Grant
Filed:
September 21, 2001
Date of Patent:
January 31, 2006
Assignee:
Elan Pharmaceuticals, Inc.
Inventors:
Roy Hom, Shumeye Mamo, Jay Tung, Andrea Gailunas, Varghese John, Lawrence Fang